← All Sponsors
SPONSOR

University of Maryland, Baltimore

Total Trials
13
Recruiting
13
Phases
EARLY_Phase 1, Phase 1, Phase 2, Phase 2

University of Maryland, Baltimore is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Polycystic Kidney Disease, Sepsis, Morbid Obesity, Pregnancy.

The trial portfolio spans EARLY_Phase 1, Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Maryland, Baltimore

How many clinical trials has University of Maryland, Baltimore sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by University of Maryland, Baltimore, of which 13 are actively recruiting participants. These trials cover conditions including Polycystic Kidney Disease, Sepsis, Morbid Obesity. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Maryland, Baltimore research focus on?
University of Maryland, Baltimore clinical trials span Polycystic Kidney Disease, Sepsis, Morbid Obesity, Pregnancy, Breast Cancer Female, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Maryland, Baltimore clinical trial?
To participate in a University of Maryland, Baltimore trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Maryland, Baltimore trials with current recruitment status updated daily.

Clinical Trials by University of Maryland, Baltimore

NCT01873235
Recruiting

PKD Clinical and Translational Core Study

Polycystic Kidney Disease
NCT05634733
Recruiting

Change in MAPSE During Treatment of Sepsis

Sepsis
NCT06199154 EARLY_Phase 1
Recruiting

Induction of Labor in Morbidly Obese Patients

Morbid Obesity
NCT03562273
Recruiting

GammaPod Registry and Quality of Life Nomogram

Breast Cancer Female
NCT07075510 Phase 1, Phase 2
Recruiting

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

Plasma Cell Disorder
NCT04201600
Recruiting

Glucose Variability and Cognition in Prediabetes

Glucose Metabolism Disorders (Including Diabetes Mellitus)
NCT05511909 Phase 2
Recruiting

Evaluating Buspirone to Treat Opioid Withdrawal

Opioid Use Disorder
NCT04545424 Phase 2
Recruiting

Trial of Therapeutic Hypothermia in Patients With ARDS

Respiratory Distress Syndrome, Adult
NCT06465290
Recruiting

Promoting Neuroplastic Changes of Patients With TBI

Traumatic Brain Injury
NCT06367608
Recruiting

MRgFUS Pallidotomy for the Treatment of Task Specific Focal Hand Dystonia (TSFD)

Task-Specific Focal Dystonia
NCT06641297
Recruiting

White Matter Plasticity in Schizophrenia

Schizophrenia Disorders
NCT06993597
Recruiting

Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy

Glaucoma
NCT06943859 Phase 2
Recruiting

Ketamine for Opioid Use Disorder

Opioid Use Disorder
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology